Against Clostridioides difficile Infection: An Update on Vaccine Development
Toxins · 01.05.2025 · 17 (5) · 222
DOI: 10.3390/toxins17050222 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Toxins, online erschienen am 01.05.2025. Verfasst von Jingyao Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking Un…. Hauptthemen laut MEDLINE: Clostridioides difficile, Bacterial Vaccines, Clostridium Infections, Vaccine Development. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, Fundamental Research Funds.
Abstract (Originalsprache)
Clostridioides difficile (C. difficile) is a major pathogen responsible for antibiotic-associated diarrhea, frequently observed in hospital settings. Due to the widespread use of antibiotics, the incidence and severity of C. difficile infection (CDI) are rising across the world. CDI is primarily driven by two homologous protein exotoxins, toxin A (TcdA) and toxin B (TcdB). Other putative virulence factors include binary toxin CDT, surface layer proteins, phosphorylated polysaccharides, and spore coat proteins. These C. difficile virulence factors are potential targets for vaccine development. Although several C. difficile vaccines have entered clinical trials, there is currently no approved vaccine on the market. This review outlines the intoxication mechanism during CDI, emphasizing the potential antigens that can be used for vaccine development. We aim to provide a comprehensive overview of the current status of research and development of C. difficile vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, China.
- Department of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
ORCID-Profile: Jingyao Wang, Songhai Tian
Förderung
- the National Natural Science Foundation of China
- Fundamental Research Funds
Zitieren
APA
Wang, J., Ma, Q., & Tian, S. (2025). Against Clostridioides difficile Infection: An Update on Vaccine Development. Toxins, 17(5), 222. https://doi.org/10.3390/toxins17050222
Vancouver
Wang J, Ma Q, Tian S. Against Clostridioides difficile Infection: An Update on Vaccine Development. Toxins. 2025;17(5):222. doi:10.3390/toxins17050222
BibTeX
@article{Wang2025,
author = {Wang, Jingyao and Ma, Qianquan and Tian, Songhai},
title = {Against Clostridioides difficile Infection: An Update on Vaccine Development},
journal = {Toxins},
year = {2025},
volume = {17},
number = {5},
pages = {222},
doi = {10.3390/toxins17050222}
}
EUVIMED